An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model

Clicks: 580
ID: 120634
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 3 articles by views in cancer immunology research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Natural killer (NK) cells are primary immune cells that target cancer cells and can be used as a therapeutic agent against pancreatic cancer. Despite the usefulness of NK cells, NK-cell therapy is limited by tumor cell inhibition of NK-cell homing to tumor sites, thereby preventing a sustained antit …
Reference Key
j2019canceran Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lee J, Kang TH, Yoo W, Choi H, Jo S, Kong K, Lee SR, Kim SU, Kim JS, Cho D, Kim J, Kim JY, Kwon ES, Kim S
Are you one of these authors? Claim your profile
Journal cancer immunology research
Year 2019
DOI
DOI not found
URL
https://www.pubmed.gov/30514792/
Keywords
Tumor National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female Disease Models Animal Antibodies cell line immunotherapy monoclonal / pharmacology* combined modality therapy disease progression pancreatic neoplasms / pathology pmid:30514792 doi:10.1158/2326-6066.cir-18-0317 jaemin lee tae heung kang seokho kim chemotaxis / drug effects chemotaxis / immunology immunoconjugates / pharmacology adoptive* / methods killer cells natural / immunology* natural / metabolism pancreatic neoplasms / immunology* pancreatic neoplasms / mortality pancreatic neoplasms / therapy* xenograft model antitumor assays

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.